OPIA Technologies Overview

  • Founded
  • 2009
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 2

OPIA Technologies General Information


Developer of medical devices in particular ocular surface sampling devices designed for diagnostic purposes. The company's services offer a technology platform for in vivo biopsies of the conjunctiva for further analysis to help diagnose the most common ocular surface disorders such as dry eye, allergies or blepharitis, enabling clients in the healthcare sector to provide innovative and reliable devices to improve the diagnosis and care of patients with ocular diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Primary Office
  • 17, Rue Moreau
  • 75012 Paris
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OPIA Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view OPIA Technologies’s complete valuation and funding history, request access »

OPIA Technologies Executive Team (1)

Name Title Board Seat Contact Info
Pierre Roy Co-Founder & Chief Executive Officer
To view OPIA Technologies’s complete executive team members history, request access »

OPIA Technologies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agoranov Accelerator/Incubator 000 0000 000000 0
Incubateur Insitut de La Vision Accelerator/Incubator Minority 000 0000 000000 0
To view OPIA Technologies’s complete investors history, request access »